Local 1546 Charity


PrintFor many years, the UFCW has had a unique partnership with the Leukemia & Lymphoma Society.   Local 1546 holds several events throughout the year to raise funds for this great cause, and every penny we raise goes to fund the research that will someday find a cure for leukemia, lymphoma, and other blood-related cancers.

As a part of our long-standing agreement with LLS, none of the money raised by the UFCW is ever used for administrative costs, or any purpose other than research.  So when Local 1546 members work hard to raise funds for this cause, they always know that the money they raise will be put to the best possible use: finding a cure!  With more than 640,000 people in the U.S. living with blood cancers — and a new patient diagnosed every 5 minutes — the need for help is great!

llsSince 1949, LLS has been dedicated to curing leukemia, lymphoma and myeloma

The Leukemia & Lymphoma Society (LLS) is the world’s largest voluntary (nonprofit) health organization dedicated to funding blood cancer research and providing education and patient services.

What Is Leukemia?

Leukemia is a type of cancer that affects the blood and bone marrow, the spongy center of bones where our blood cells are formed. The disease develops when blood cells produced in the bone marrow grow out of control.

An estimated 52,380 new cases of leukemia are expected to be diagnosed in the United States in 2014.

What Is Lymphoma?

Lymphoma is the name for a group of blood cancers that develop in the lymphatic system. The two main types are Hodgkin lymphoma and non-Hodgkin lymphoma (NHL).

In 2014, there are expected to be 79,990 new cases of lymphoma diagnosed in the US (9,190 cases of Hodgkin lymphoma, 70,800 cases of NHL).

Hodgkin lymphoma has characteristics that distinguish it from other diseases classified as lymphoma, including the presence of Reed-Sternberg cells. These are large, cancerous cells found in Hodgkin lymphoma tissues, named for the scientists who first identified them. Hodgkin lymphoma is one of the most curable forms of cancer.

NHL represents a diverse group of diseases distinguished by the characteristics of the cancer cells associated with each disease type. Most people with NHL have a B-cell type of NHL (about 85 percent). The others have a T-cell type or an NK-cell type of lymphoma. Some patients with fast-growing NHL can be cured. For patients with slow-growing NHL, treatment may keep the disease in check for many years.

What Is Myeloma?

Myeloma is a type of cancer that begins in the bone marrow. It affects the plasma cells.

Myeloma has several forms:

  • Multiple myeloma is most common: More than 90 percent of people with myeloma have this type. Multiple myeloma affects several different areas of the body.
  • Plasmacytoma – only one site of myeloma cells evident in the body, such as in the bone, skin, muscle, or lung.
  • Localized myeloma – a few neighboring sites evident.
  • Extramedullary myeloma – involvement of tissue other than bone marrow, such as skin, muscles or lungs.

Doctors divide myeloma into groups that describe how rapidly or slowly the disease is progressing:

  • Asymptomatic or smoldering myeloma progresses slowly and has no symptoms even though the patient has the disease.
  • Symptomatic myeloma has related symptoms such as anemia, kidney damage and bone disease.

Myeloma belongs to a spectrum of disorders referred to as “plasma cell dyscrasia.”

Click here to learn more about the Leukemia and Lymphoma Society.